• Drugs for topical therapy in acute inflammatory diseases of the oropharynx in children

Drugs for topical therapy in acute inflammatory diseases of the oropharynx in children

SOVREMENNAYA PEDIATRIYA.2018.6(94):98-102; doi 10.15574/SP.2018.94.98

Marushko Yu. V., Asonov A. O.
Bogomolets National Medical University, Kyiv, Ukraine

Respiratory diseases remain the most common pathology of a person. In children, the cause of frequent respiratory infections is the immaturity of the immune

system in general and, in particular, local immunity, reduced ability of the body to produce interferon, reduced sIgA content, lysozyme. Addition of lysozyme(

containing drug Liosobact® and Stomatidine® is an effective remedy for local therapy of acute inflammatory diseases of the oropharynx of various etiologies

in frequently(infrequent children.

Key words: acute respiratory diseases, children, lysozyme, Lysobact, Stomatidine.

REFERENCES

1. Albitskiy VYu, Baranov AA, Kamaev IA, Ogneva ML. (2003). Chasto boleyuschie deti. N Novgorod: Izd-vo NGMA: 180.

2. Burmak YuG, Karetskaya IG, Cherepahina LP i dr. (2003). Opyit primeneniya Lisobakta v komplekse lecheniya ostryih respiratono-virusnyih zabolevaniy u detey. Primenenie lisobakta vo vrachebnoy praktike. Kiev: 23—25.

3. Ershova IB, Shirina TV. (2008). Problema chasto i dlitelno boleyuschih detey i metodyi optimizatsii ih lecheniya. Zdorove rebenka. 2(11): 59—61.

4. Kuznetsov SV, Beletskaya AA, Kopeychenko TS, Mushenko LV, Rozhenova AS, Hamhidko NL, Glebova LN. (2003). Effektivnost ispolzovaniya preparata Lisobakt v kompleksnoy terapii detey, bolnyih ostryimi tonzillitami. Primenenie lisobakta vo vrachebnoy praktike. Kiev: 19—22.

5. Marushko YuV, Movan OS, Marushko TV. (2014). Funktsionuvannia systemy mistsevoho imunitetu ta yii osoblyvosti v ditei, yaki chasto khvoriiut na respiratorni infektsii. Ukrainskyi medychnyi chasopys. 1(99): 41—45.

6. Pogorelova OO, Gorelov AV, Usenko DV, Ploskireva AA. (2015). Opyit primeneniya metabolicheskogo prebiotika v lechenii ostryih respiratornyih zabolevaniy u detey. Voprosyi prakticheskoy pediatrii. 10; 4: 61—65.

7. Pogorelova OO, Usenko DV, Ardatskaya MD, Dikaya AV, Gorelov AV. (2009). Otsenka effektivnosti Lizobakta v lechenii ostryih respiratornyih zabolevaniy u detey. Infektsionnyie bolezni. 7(1): 69—72.

8. Pogorelova OO. (2017). Obosnovanie i effektivnost novyih metodov patogeneticheskoy terapii ostryih respiratornyih infektsiy u detey. Moskva.

9. Romantsov MG. (2008). Ratsionalnaya farmakoterapiya chasto boleyuschih detey. Sankt-Peterburg: 76.

10. Chernyshova LI, Yakymovych SA, Donskoi BV, Hlaziuk LV. (2012). Zakhysna rol mistsevoho imunitetu u profilaktytsi zakhvoriuvan verkhnikh dykhalnykh shliakhiv u ditei. Sovremennaya pediatriya. 4(44): 104—107.

11. Yulish EI. (2009). Hronicheskiy tonzillit u detey. Zdorove rebenka. 6(21): 58—66.

12. Yulish EI. (2010). Faktoryi mestnogo immuniteta pri respiratornyih infektsiyah i metodyi ih aktivatsii. Zdorove rebenka. 5.

13. Aghamohammadi A, Abolhassani H, Mohammadinejad P, Rezaei N. (2012). The approach to children with recurrent infections. Iran J Allergy Asthma Immunol. 11(2): 89—109. PMid:22761184

14. Bene MC, Faure GC. (2003). Ribosomal immunotherapy for recurrent respiratory tract infections in children. Paediatr Drugs. 5(4): 223—228. https://doi.org/10.2165/00128072-200305040-00002; PMid:12662118

15. Chernyshov AV, Melnicov OF. (1992). Tonsillar lymphocyte subsets in tonsillitis and hyperplasia. 7th Internat Congress of Mucosal Immunology. Prague, Czechoslovakia, August 16—20, 1992. Abstr. Prague: 41.

16. Dajani R, Zove S, Taft P. (2005). Lisozime secretion by submucoasal glands protects the airway from bacterial. Ann J Res Cell Mol Biol. 32(6): 548—52. https://doi.org/10.1165/rcmb.2005-0059OC; PMid:15746432 PMCid:PMC2715323

17. Rogan M, Geraghty P, Greene C. (2006). Antimicrobial proteins and polypeptides in pulmonary innate defense. Respir Res. 7(1): 29. https://doi.org/10.1186/1465-9921-7-29; PMid:16503962 PMCid:PMC1386663

18. Williams BG, Gouws E, Boschi-Pinto C, Bryce C, Dye C. (2002). Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet. Infect. Dis. 2: 25—32. https://doi.org/10.1016/S1473-3099(01)00170-0

Article received: Mar 21, 2018. Accepted for publication: Oct 08, 2018.